🟢 Strong Evidence
Researchers at Stanford University have developed a method to measure aging separately in 11 organs using a single blood test, revealing that approximately 1 in 5 people experience organ-specific aging at rates substantially different from their overall biological age. The technique, based on plasma proteomics analysis published in Nature (2023), identifies organ-leaked proteins that serve as aging markers for the heart, brain, liver, lungs, kidneys, and other vital systems. This advancement challenges the traditional assumption that aging occurs uniformly across the human body.
Key takeaways
- Approximately 20% of the population has at least one organ aging significantly faster than the rest of their body, according to Oh et al. (Nature, 2023)
- Accelerated heart aging alone increases heart failure risk by 250%, and organ-specific aging clocks measured from a baseline blood draw predicted 30 different age-related diseases over 20 years in the Whitehall II cohort (Lancet Digital Health, 2025)
- Six age-related diseases were predicted exclusively by accelerated aging in their corresponding organ system, enabling precision risk stratification beyond current biomarkers
Study at a Glance
| Primary source | Nature |
| Study design | Cross-cohort validation and longitudinal follow-up |
| Sample size | 5,676 adults in validation cohort; 6,235 in 20-year prospective follow-up |
| Population | Middle-aged adults across 5 independent cohorts |
| Country | United States (validation); United Kingdom (Whitehall II) |
Organ-Specific Disease Prediction from Plasma Proteomics
Relative risk increase for age-related diseases driven by accelerated organ aging, Whitehall II cohort, 20-year follow-up
Source: Kivimäki et al., Lancet Digital Health, 2025 | Georgian Medical Journal News
How organ-specific aging clocks work
Each organ naturally leaks specific proteins into the bloodstream—hepatic proteins from the liver, pancreatic proteins from the pancreas, and cardiac proteins from the heart, among others. Researchers at Stanford applied plasma proteomics, a technique measuring thousands of proteins simultaneously from a single blood draw, to identify organ-specific aging signatures. Machine learning algorithms then constructed separate biological aging clocks for each organ based on the protein expression patterns observed.
The approach was validated across 5,676 adults in 5 independent cohorts (Nature, 2023), confirming that organ-specific aging clocks are reproducible and clinically meaningful. This method offers a granular alternative to single “biological age” scores that collapse all aging signals into one number, potentially masking important organ-level risk.
Twenty-year outcomes reveal organ-specific disease prediction
The real-world predictive power of these organ aging clocks emerged from analysis of the Whitehall II cohort, which tracked 6,235 middle-aged adults for two decades (Lancet Digital Health, 2025). Organ ages measured from a single baseline blood draw predicted 30 different age-related diseases over the following 20 years. Critically, six diseases were predicted exclusively by aging in their corresponding organ, demonstrating that organ-specific aging clocks capture disease risk not captured by conventional biomarkers.
For example, people whose liver was aging faster than the rest of their body were more than twice as likely to develop liver failure. Accelerated heart aging raised the risk of dilated cardiomyopathy by approximately two-thirds and chronic heart failure by approximately 50%. Accelerated lung aging raised lung cancer risk by roughly 30%. These associations persisted independent of chronological age, suggesting that organ aging captures a distinct dimension of disease risk.
Clinical and research implications for precision medicine
The organ-specific aging model challenges the traditional gerontology assumption that biological age is uniform across body systems. A 50-year-old person whose heart is aging at the rate of a 53-year-old while their kidneys remain at 39 has a fundamentally different clinical risk profile than one with the opposite pattern. This distinction has direct implications for clinical decision-making and risk stratification, enabling more precise preventive strategies tailored to each patient’s organ-specific aging trajectory.
Current commercial “biological age” tests, which collapse multiple aging signals into a single output, may obscure these organ-level differences. Adoption of organ-specific aging clocks in clinical practice could shift risk assessment from global to organ-targeted approaches, allowing earlier intervention in systems aging at accelerated rates. Future research should investigate whether organ-specific interventions—tailored exercise, diet, or pharmacotherapy—can decelerate aging in individual organs and reduce organ-specific disease risk.
Approximately 20% of the population has at least one organ aging significantly faster than the rest of their body, and accelerated heart aging alone confers a 250% higher risk of heart failure.
— Oh et al., Stanford University (Nature, 2023)
What this means
A single blood test measuring organ-specific aging clocks may provide earlier warning of individual disease risks and support personalized prevention strategies. Patients with faster-aging organs in specific systems could discuss targeted screening or lifestyle modifications with their clinicians.
Organ-specific aging clocks from plasma proteomics offer a new dimension of risk stratification beyond chronological age and conventional biomarkers. This enables more precise counseling on disease prevention and earlier intervention in patients with accelerated organ aging in high-risk systems.
Widespread adoption of organ-specific aging clocks could shift public health screening from age-based to biology-based approaches, potentially improving cost-effectiveness of preventive programs and reducing age-related disease burden. Health systems should evaluate incorporation into preventive medicine and aging research frameworks.
Frequently asked questions
Can organ-specific aging clocks predict disease in all organs equally well?
No. According to the Whitehall II study (Lancet Digital Health, 2025), six age-related diseases were predicted exclusively by aging in their corresponding organ, while other diseases showed multi-organ aging patterns. This specificity strengthens the clinical utility of organ-specific clocks but also indicates that disease risk often involves multiple aging pathways.
How does organ-specific aging compare to current biological age tests?
Current commercial biological age tests typically collapse all aging information into a single “biological age” score. Organ-specific aging clocks, by contrast, measure 11 separate aging trajectories from a single blood draw (Nature, 2023), preserving clinically important information about which organ systems are aging fastest and which are aging slowest.
Are organ-specific aging clocks ready for clinical use?
The science is strong—validation across multiple cohorts and 20-year prospective follow-up demonstrate predictive accuracy. However, clinical translation requires further research into how clinicians should act on these results and whether organ-targeted interventions can slow aging in individual systems. Larger implementation studies in diverse populations are also needed.
These findings from Stanford and the Whitehall II cohort represent a significant shift in how researchers and clinicians think about biological aging. Instead of treating aging as a single, uniform process, organ-specific aging clocks enable recognition that the body ages as a heterogeneous collection of systems—each with its own trajectory and risk profile. As plasma proteomics becomes more accessible and machine learning algorithms improve, adoption of organ-specific aging assessment in clinical practice may become a standard component of precision preventive medicine and aging research.
Source: Your body doesn’t age as one unit
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
